select trial semaglutide nejm was published today in NEJM. Below, I summarize the trial and the drug in this thread.... - Dr Shailesh Singh Beyond obesity: Novo's SELECT re-defines

Thankfully, Richards cancer levels looked good, so Dr

We want to make sure we offer the real, authentic Wegovy and Ozempic where patients seek care, David Moore, president of Novo Nordisk U.S., told NBC News

Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation

Agents that provide benefits beyond glucose lowering - such as reducing heart disease risk - are rewarded with broader guideline adoption and wider clinical utilization

They made sure I felt comfortable throughout the entire process, and I genuinely appreciated their professionalism

On lateral septum-like characteristics of outputs from the accumbal hedonic "hotspot" of Pecina and Berridge with commentary on the transitional nature of basal forebrain "boundaries"